MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
November 24, 2021

5 Years Later: Olaparib for Advanced BRCA-mutated Ovarian Cancer Extends Progression-Free Survival

By Mara Shapiro, Staff Writer
A 5-year follow-up of patients with newly diagnosed advanced BRCA-mutated ovarian cancer showed that olaparib continues to improve progression-free survival even past treatment completion...
5 Years Later: Olaparib for Advanced BRCA-mutated Ovarian Cancer Extends Progression-Free Survival
November 23, 2021

Mepolizumab Gains European Approval in Additional Eosinophil-driven Diseases

By MD /alert
The European Commission approved mepolizumab as an add-on treatment in three additional eosinophil-driven diseases: hypereosinophilic syndrome, eosinophilic granulomatosis with polyangiitis, and chronic rhinosinusitis with nasal polyps...
Mepolizumab Gains European Approval in Additional Eosinophil-driven Diseases
November 22, 2021

Upadacitinib Use Increases Risk for Herpes Zoster in Patients with Rheumatoid Arthritis

By Adam Hochron, Staff Writer
According to a pooled analysis study, patients with rheumatoid arthritis treated with upadacitinib are at greater risk of developing herpes zoster than those treated with methotrexate or in combination with adalimumab...
Upadacitinib Use Increases Risk for Herpes Zoster in Patients with Rheumatoid Arthritis
November 19, 2021

Non-invasive Predictors Of Nonasthmatic Eosinophilic Bronchitis Remain Elusive

By Jeff Craven, MD /alert Contributor

Non-invasive markers such as peripheral blood eosinophil (PBE) count and fractional exhaled nitric oxide (FeNO) are not reliable predictors of nonasthmatic eosinophilic bronchitis (NAEB)...
Non-invasive Predictors Of Nonasthmatic Eosinophilic Bronchitis Remain Elusive
November 18, 2021

Rituximab Biosimilar Demonstrates Long-Term Noninferiority for Patients With Advanced Follicular Lymphoma

By Cameron Kelsall, MD /alert Contributor
Treatment with CT-P10, a rituximab biosimilar, resulted in similar long-term efficacy as the reference product for patients with advanced follicular lymphoma...
Rituximab Biosimilar Demonstrates Long-Term Noninferiority for Patients With Advanced Follicular Lymphoma
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Omicron variant may have picked up a piece of common-cold virus

By Nancy Lapid NEW YORK (Reuters) - The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus - Read More »

Pre-eclampsia/eclampsia tied to increased risk of heart failure for at least 10 years

By Marilynn Larkin NEW YORK (Reuters Health) - Women with pre-eclampsia/eclampsia were at increased risk for future heart failure (HF) for up to a decade in a large cohort study. "While preeclampsia Read More »

Fat cell alterations implicated in breast cancer metastases

By Marilynn Larkin NEW YORK (Reuters Health) - In preclinical experiments, researchers have uncovered a mechanism linking fat cells altered by type 2 diabetes or insulin resistance to breast cancer Read More »

At least one year on bisphosphonates needed for fracture prevention

By Lisa Rapaport (Reuters Health) - It takes 12.4 months of bisphosphonate therapy to prevent one nonvertebral fracture per 100 postmenopausal women with osteoporosis, a meta-analysis of randomized Read More »

REUTERS NEXT-Researcher questions China's population data, says it may be lower

By Jane Lanhee Lee (Reuters) - China may be downplaying how fast its population is shrinking, and a recent policy to promote three-child families has poor chances to improve birth rates, a fertility Read More »

FDA clears use of Lilly's COVID-19 antibody therapy for kids

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, Read More »

EXPLAINER-Could the Omicron variant bring milder illness?

By Deena Beasley (Reuters) - The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of Read More »

Omicron outbreak at Norway Christmas party is biggest outside S. Africa -authorities

By Gwladys Fouche and Nerijus Adomaitis OSLO (Reuters) - At least 13 people in Oslo have been infected with the Omicron variant of the coronavirus following a corporate Christmas party described as a Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.